SCHEMBL23899043

SCHEMBL23899043

Nc1ccc(NC(=O)C2CCC(C(=O)Nc3ccc(N)cc3)CC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.67
▸ KMT2A Q03164 4/20 0.65
▸ MEN1 O00255 3/20 0.65
▸ LMNA P02545 2/20 0.65
▸ MAPT P10636 3/20 0.62
▸ GAA P10253 2/20 0.62
▸ GFER P55789 1/20 0.62
▸ PTPN1 P18031 1/20 0.59
▸ RAB9A P51151 6/20 0.57
▸ NPC1 O15118 3/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ CASP3 P42574 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ SENP7 Q9BQF6 1/20 0.57
▸ HPGD P15428 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.54
▸ GLA P06280 1/20 0.54
▸ RXFP1 Q9HBX9 1/20 0.54
▸ EPHX1 P07099 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL116361 1.00 NAMPT (0.67) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL23898941 1.00 NAMPT (0.67) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL4448787 0.92 PTPN1 (0.71) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL678484 0.91 PTPN1 (0.74) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL2717891 0.88 ULK1 (0.60) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL3093740 0.88 ALDH1A1 (0.55) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL14618675 0.82 NAMPT (0.69) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL25845705 0.81 NAMPT (0.62) NAMPTKMT2AMEN1LMNAMAPT
SCHEMBL4564743 0.80 ULK1 (0.64) NAMPTKMT2ALMNAMAPTGAA
SCHEMBL10113961 0.80 NAMPT (0.49) NAMPTKMT2AMEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309630-A1 ALLOSTERIC INHIBITOR OF WEE1 KINASE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. 2021-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309630-A1 ALLOSTERIC INHIBITOR OF WEE1 KINASE WEE1, WEE2, PAXBP1 NAMPT 1104/4885KMT2A 581/4885MEN1 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback